Enovix Corporation (NASDAQ:ENVX) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Enovix Corporation (NASDAQ:ENVX) has been given a consensus recommendation of “Moderate Buy” by the ten brokerages that are presently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, one has given a hold rating and seven have issued a buy rating on the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $12.6364.

A number of research analysts recently issued reports on ENVX shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of Enovix in a report on Friday, April 10th. Benchmark decreased their target price on Enovix from $25.00 to $15.00 and set a “buy” rating for the company in a report on Thursday, May 14th. JPMorgan Chase & Co. lowered Enovix from a “neutral” rating to an “underweight” rating in a report on Wednesday, May 6th. Bank of America started coverage on Enovix in a report on Thursday, March 12th. They issued a “neutral” rating and a $6.00 target price for the company. Finally, Wall Street Zen upgraded Enovix from a “strong sell” rating to a “sell” rating in a research note on Saturday, May 16th.

Institutional Trading of Enovix

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Principal Financial Group Inc. raised its stake in Enovix by 7.6% in the third quarter. Principal Financial Group Inc. now owns 12,613 shares of the company’s stock valued at $126,000 after buying an additional 895 shares in the last quarter. Private Advisor Group LLC raised its stake in Enovix by 2.7% in the third quarter. Private Advisor Group LLC now owns 46,519 shares of the company’s stock valued at $464,000 after buying an additional 1,242 shares in the last quarter. Parallel Advisors LLC raised its stake in Enovix by 51.9% in the third quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock valued at $39,000 after buying an additional 1,342 shares in the last quarter. Equitable Holdings Inc. raised its stake in Enovix by 10.9% in the third quarter. Equitable Holdings Inc. now owns 13,700 shares of the company’s stock valued at $137,000 after buying an additional 1,342 shares in the last quarter. Finally, Claro Advisors LLC raised its stake in Enovix by 2.9% in the third quarter. Claro Advisors LLC now owns 64,578 shares of the company’s stock valued at $644,000 after buying an additional 1,850 shares in the last quarter. 50.92% of the stock is currently owned by institutional investors and hedge funds.

Enovix Trading Down 6.4%

NASDAQ:ENVX opened at $6.63 on Wednesday. The firm has a market cap of $1.45 billion, a PE ratio of -7.99 and a beta of 2.27. The stock has a fifty day moving average price of $6.74 and a 200 day moving average price of $6.74. Enovix has a 12-month low of $4.61 and a 12-month high of $16.49. The company has a current ratio of 10.97, a quick ratio of 10.65 and a debt-to-equity ratio of 2.14.

Enovix (NASDAQ:ENVX) last released its earnings results on Wednesday, May 13th. The company reported ($0.14) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.01. The firm had revenue of $7.60 million during the quarter, compared to analyst estimates of $6.95 million. Enovix had a negative return on equity of 64.28% and a negative net margin of 499.64%.Enovix’s revenue was up 49.1% compared to the same quarter last year. During the same period last year, the business posted ($0.15) earnings per share. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. Sell-side analysts anticipate that Enovix will post -0.79 earnings per share for the current fiscal year.

About Enovix

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.